Aashis Thapa

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Integrative analysis of drug response and clinical outcome in acute myeloid leukemia”.

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.07.002

N/A

0DataRank · unranked

373 citations

Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson +89 more

Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia

Journal of Controlled Release(2023)10.1016/j.jconrel.2023.07.045

N/A

0DataRank · unranked

6 citations

Madison L. Chimenti, Dan Y. Zhang, Evelyn Kendall Williams, Samuel G. Moore, Gabrielle M. Humber +16 more

Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.13.531236

N/A

0DataRank · unranked

0 citations

Juhi Jain, Aashis Thapa, Min Qui, Lacey A. Birnbaum, Samuel G. Moore +12 more

MERTK Inhibition as a Targeted Novel Cancer Therapy

International Journal of Molecular Sciences(2024)10.3390/ijms25147660

N/A

0DataRank · unranked

13 citations

Alisha Holtzhausen, Aashis Thapa, Justus M. Huelse, Douglas K. Graham, H. Shelton Earp +1 more

MERTK Inhibition as a Targeted Novel Cancer Therapy

UNC Libraries(2024)10.17615/q9p8-mz87

N/A

0DataRank · unranked

0 citations

Alisha Holtzhausen, Douglas K. Graham, Aashis Thapa, H. Shelton Earp, K.M. Tanim +1 more